CSURGSU
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Centenial Surgical do?
Centenial Surgical Suture Ltd. specializes in manufacturing a wide range of sterile needled sutures, including absorbable natural and synthetic sutures, non-absorbable sutures, and various medical devices for surgical procedures.
Who are the competitors of Centenial Surgical?
Centenial Surgical major competitors are KMS Medisurgi, GKB Ophthalmics, Amkay Products, Shree Pacetronix, Transpact Enterprise, Hemant Surgical Inds, Laser Eyecare. Market Cap of Centenial Surgical is ₹52 Crs. While the median market cap of its peers are ₹37 Crs.
Is Centenial Surgical financially stable compared to its competitors?
Centenial Surgical seems to be less financially stable compared to its competitors. Altman Z score of Centenial Surgical is 2.43 and is ranked 5 out of its 8 competitors.
Does Centenial Surgical pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Centenial Surgical latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Centenial Surgical allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory
How strong is Centenial Surgical balance sheet?
Balance sheet of Centenial Surgical is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Centenial Surgical improving?
The profit is oscillating. The profit of Centenial Surgical is -₹1.6 Crs for TTM, ₹1.13 Crs for Mar 2024 and ₹0.89 Crs for Mar 2023.
Is the debt of Centenial Surgical increasing or decreasing?
The net debt of Centenial Surgical is decreasing. Latest net debt of Centenial Surgical is ₹12.04 Crs as of Mar-25. This is less than Mar-24 when it was ₹13.09 Crs.
Is Centenial Surgical stock expensive?
Centenial Surgical is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Centenial Surgical is -35.36, while 3 year average PE is 28.04. Also latest EV/EBITDA of Centenial Surgical is 10.22 while 3yr average is 5.83.
Has the share price of Centenial Surgical grown faster than its competition?
Centenial Surgical has given better returns compared to its competitors. Centenial Surgical has grown at ~39.83% over the last 1yrs while peers have grown at a median rate of -29.28%
Is the promoter bullish about Centenial Surgical?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Centenial Surgical is 46.89% and last quarter promoter holding is 46.89%.
Are mutual funds buying/selling Centenial Surgical?
There is Insufficient data to gauge this.